RJA
MDT icon

Ross\Johnson & Associates’s Medtronic MDT Stock Holding History

Ross\Johnson & Associates’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$18.6K Hold
238
– – 0.29% 32
2026
Q1 		$20.6K Sell
238
-1
-0.4% -$96 0.37% 26
2025
Q4 		$23K Sell
239
-1
-0.4% -$97 0.43% 25
2025
Q3 		$22.9K Hold
240
– – 0.43% 24
2025
Q2 		$20.9K Sell
240
-90
-27% -$7.63K 0.43% 23
2025
Q1 		$29.7K Hold
330
– – 0.51% 28
2024
Q4 		$26.4K Buy
+330
New +$28.6K 0.61% 18

Other funds holding MDT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Ross\Johnson & Associates's MDT Position: Q2 2026 in Review

Ross\Johnson & Associates held its Medtronic (MDT) position steady in Q2 2026 at 238 shares worth $18.6K. The position accounts for 0.29% of the portfolio, ranked #32.

Ross\Johnson & Associates first reported a position in MDT in Q4 2024 and has held it in 7 quarters since. The position peaked at $29.7K in Q1 2025. 2,138 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Ross\Johnson & Associates held 238 shares of Medtronic worth $18.6K as of Q2 2026.
  • Ross\Johnson & Associates left its Medtronic share count unchanged in Q2 2026.
  • Medtronic made up 0.29% of Ross\Johnson & Associates's portfolio in Q2 2026, its #32 holding.
  • Ross\Johnson & Associates first reported a position in Medtronic in Q4 2024 and has held it in 7 quarters since.
  • Ross\Johnson & Associates's Medtronic position peaked at $29.7K in Q1 2025.
  • 2,138 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Ross\Johnson & Associates's 13F filing for Q2 2026, filed 14 Aug 2026.